Cerebrovascular Disease and Statins

Elevated low-density lipoprotein-cholesterol (LDL-C) is a causal factor for the development of atherosclerotic cardiovascular disease (ASCVD); accordingly, LDL-C lowering is associated with a decreased risk of progression of atherosclerotic plaques and development of complications. Currently, statin...

Descripción completa

Detalles Bibliográficos
Autores principales: Beltrán Romero, Luis M., Vallejo-Vaz, Antonio J., Muñiz Grijalvo, Ovidio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674469/
https://www.ncbi.nlm.nih.gov/pubmed/34926626
http://dx.doi.org/10.3389/fcvm.2021.778740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674469/
https://www.ncbi.nlm.nih.gov/pubmed/34926626
http://dx.doi.org/10.3389/fcvm.2021.778740

Ejemplares similares